Why GMP and GDP Audits Matter for Pharmaceutical Quality and Patient Safety
Introduction
GMP and GDP audits help protect medicine quality and patient safety.
Quality control does not end at the factory gate. After manufacture, medicines must stay safe during storage, transport and delivery.
Written procedures are important. Yet having them on paper does not prove they work. You need to check how they work in real life.
This is where audits help. A good audit can find gaps, highlight risks and support fixes. When you act on findings, you can build stronger systems and reduce risk.
What Are GMP and GDP Audits?
What Is a GMP Audit?
Good Manufacturing Practice (GMP) covers how medicines are made.
The European Commission’s EudraLex Volume 4 sets the main EU rules for GMP.
The US FDA also sets Current Good Manufacturing Practice (CGMP) rules. These rules cover quality systems, raw materials, processes, labs and how you handle issues.
A GMP audit checks if these controls work in practice. It looks at sites, equipment, staff, papers and systems. The goal is to see if you meet GMP rules and if your controls work.
Need help? Inglasia offers GMP Auditing Services for independent checks.
What Is a GDP Audit?
Good Distribution Practice (GDP) covers storage, transport and delivery of medicines.
The European Commission’s GDP guide sets EU rules for this. It says poor distribution can harm product quality.
Risks can appear after manufacture. Bad storage, wrong temperatures or poor transport can damage medicines.
So a GDP audit looks at stores, trucks, cold-chain, handling, records and suppliers.
Inglasia also offers GDP Auditing Services to check your distribution controls.
How GMP and GDP Controls Work Together
GMP and GDP cover different steps. Yet they work as one chain.
GMP builds quality in. It controls how you make the product.
GDP keeps quality safe. It controls how you store and move the product.
Together they protect medicines from factory to patient. The end goal is not just compliance. It is safe, quality medicines for patients.
Why GMP and GDP Audits Matter
Quality systems change. Staff change roles. You add new suppliers. You buy new equipment. Old SOPs may no longer fit.
So ask: Do our paper controls still work in real life?
EU GMP Chapter 9 talks about self-inspection. It says you should check GMP compliance and plan fixes. It also says outside audits by experts can help.
For this reason, audits should be more than a tick-box task.
A good audit watches how people work. It checks if they follow SOPs. It finds weak spots that could harm quality.
You can also use a risk-based GMP audit. This helps you focus time on high-risk areas.
Finding an issue is only step one. Next you must find the cause, fix it and check the fix worked.
5 Common Compliance Gaps GMP and GDP Audits Can Identify
Each company has different risks. So findings will differ. But some gaps come up often.
1. Temperature Monitoring and Cold-Chain Controls
Many medicines need tight temperature control.
An audit will check if your temp limits are clear. It will check if your loggers work and if your records prove control.
For cold-chain items, poor control can harm product quality. Audits help you catch this early.
2. Outdated SOPs and Poor Documentation
SOPs must match what staff really do.
Old SOPs cause confusion. Poor version control means staff may use the wrong copy. Missing records mean you cannot prove the task was done.
Good docs are not just admin. They show your system works.
3. Supplier and Third-Party Management
Most firms use outside partners. These can be suppliers, shippers, warehouses and distributors.
These partners affect quality. So you need clear checks to qualify them and watch them over time.
An audit tests if those checks happen in real life, not just in contracts.
Learn more in Inglasia’s Common GMP Audit Findings guide.
4. Training and Data Integrity
Quality needs trained people.
Staff need training for their role. Training must stay current when jobs change. Records must be true, full and easy to trace.
An audit can spot gaps in training or records before they cause big issues.
5. Weak CAPA and Recurring Issues
Finding a gap is not the same as fixing it.
CAPA means you find the root cause, fix it and stop it coming back.
Good CAPA asks why it happened. It checks if the fix worked. If the same issue keeps coming back, you likely fixed the symptom, not the cause.
A GMP Compliance Audit Checklist can help you prep. But always shape it to your own risks.
From Compliance Gaps to Patient Safety
Quality controls matter because patients matter.
FDA says CGMP controls help ensure medicines meet quality specs. They help stop mix-ups, contamination and errors.
Similarly, the European Commission’s GDP guide says poor distribution can harm quality.
An audit helps you connect the dots:
- Find the weak spot. The audit spots a gap.
- Check the risk. You ask how it could affect quality.
- Find the cause. You dig into why it happened.
- Fix it. You act on the root cause.
- Check the fix. You confirm it worked.
- Keep watching. You monitor for repeat issues.
No audit can promise zero issues. But it can help you find and fix weak spots before they grow. Good follow-up is as vital as the audit itself.
Internal vs. Independent Audits: The Value of an External Perspective
Internal Audits
Internal audits are done by your own team.
They give you insight into daily work. Your team knows the site, history and quirks. So they can spot trends early. They help with ongoing checks.
Independent or External Audits
External audits bring fresh eyes.
An outsider may see risks your team has missed. This is normal when you see the same process each day. Outside experts can also bring deep pharma know-how.
In fact, EU GMP Chapter 9 says outside audits by experts may be useful.
External audits should not replace internal ones. Instead they can add to them.
Read more in Inglasia’s guide to internal vs. external GMP audits.
Key Benefits of Regular GMP and GDP Audits
Identifying Compliance Gaps
Audits show you where gaps exist. These gaps may be in process, docs, systems or controls. Once you see them, you can plan action.
Reducing Quality and Compliance Risks
Not all findings carry the same risk.
ICH Q9 Quality Risk Management gives tools to manage quality risk. Audit results help you pick what to fix first.
Strengthening Quality Systems
Audits do more than list faults. They show how to make systems better. Fixing repeat issues builds a tougher, more reliable system.
Improving Supplier and Third-Party Oversight
Suppliers can affect your product. This is key when others store or move your goods. Audits give you a clear view of how they work.
Supporting Regulatory and Inspection Readiness
Regular audits help you find issues before inspectors do.
No audit can promise a pass. But a strong system plus quick fixes helps you stay ready.
Supporting Continuous Improvement
Do not audit only before an inspection. Use findings to learn and improve over time. FDA also talks about using quality metrics to track and improve.
Supporting Product Quality and Patient Safety
Think of it as: Audit. Find. Fix. Check. Improve.
By finding weak spots and fixing them, you protect product quality. In turn, you help support patient safety.
How Inglasia Supports GMP and GDP Auditing
The Inglasia Approach: 7 Pillars of Quality
Inglasia’s seven pillars are the core of a Quality pro:
- Question – Always seek to learn
- Understand – Give time to learn
- Accept – Things will go wrong
- Liaise – Collaborate with others
- Inform – Speak out
- Trust – Seek help and give help
- You – Live by all of the above
Pharmaceutical Quality Expertise
Inglasia Pharma Solutions started in 2011.
We help pharma and biotech firms with GMP and GDP. Our team has skilled Quality pros who support your needs.
Flexible Support Models
Different firms need different help. So we offer flexible models.
One-Off Audits
You can hire us for one audit. This can be a supplier, partner or site audit.
External Quality Department
Need more help? We can act as your outside Quality team. This can be ad-hoc help or ongoing cover. It gives you expert help without hiring full-time staff.
From Audit Findings to Practical Improvement
Our audits are tailored. We look for risks and areas to improve.
Our GDP service covers suppliers, docs, transport and temp control. The goal is not just to find faults. We help you see weak spots and plan how to improve.
No single rule fits all.
EU GMP Chapter 9 says you should check areas on a set plan. How often depends on risk, complexity, past findings and history. Use a risk-based plan to set timing.
GDP timing also varies. Think about your work, supply-chain risk, past issues and partners.
EU GDP rules say you need a self-inspection plan for GDP. For help, see Inglasia’s GDP Compliance Audit Checklist.
There is no set time.
Time depends on scope and complexity. Site count, size and goals also affect time. A small supplier check takes less time than a full system review.
Yes, if they affect quality or distribution.
This can include suppliers, shippers and warehouse firms. You need clear checks to qualify them and watch them. Audits give you extra insight into how they work.
It depends on the finding.
A typical path is:
Finding
Risk check
Root cause
Fix
Check fix
Follow-up
Do not just close it on paper. Check if the fix solved the real cause and stops it coming back.
Conclusion
GMP and GDP audits are more than compliance checks.
They let you look at how your system works day to day. They help you find gaps and fix them.
In short: Find gaps. Check risk. Fix cause. Build controls. Protect quality. Support safety.
Regular audits help you keep strong systems, watch suppliers and stay ready for inspection.
Most of all, audits should drive change. When you probe findings, fix root causes and check results, audits become tools for real, lasting gain.
Inglasia provides tailored GMP auditing and GDP auditing. You can use us for one-off audits or as your outside Quality team.
Learn more at Inglasia Pharma Solutions or contact our team.